Honduras vs Netherlands: Previously treated cases tested for RR-/MDR-TB
Honduras
76.0%
in 2024
Netherlands
75.0%
in 2024
Honduras rank
120th
Netherlands rank
123rd
Previously treated cases tested for RR-/MDR-TB over time
- Honduras
- Netherlands
How they compare
Honduras currently reports 76.0% against 75.0% in Netherlands, a difference of 1.0%.
The two have swapped places 7 times across 17 shared years of data; in 2005 it was Netherlands ahead.
Honduras ranks 120th and Netherlands ranks 123rd of 180 countries.
Across the 3 decades both report, Honduras averaged higher in 1 and Netherlands in 2.
Head to head by decade
| Decade | Honduras | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.7% | 64.3% | 37.7% | Netherlands |
| 2010s | 60.2% | 67.2% | 7.0% | Netherlands |
| 2020s | 77.0% | 72.2% | 4.8% | Honduras |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Honduras or Netherlands?
- Honduras, at 76.0% against 75.0% in Netherlands as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Honduras and Netherlands?
- 1.0%, with Honduras ahead.
- How many years of comparable data are there for Honduras and Netherlands?
- 17 years are reported by both, from 2005 to 2024.
- How do Honduras and Netherlands rank globally for previously treated cases tested for rr-/mdr-tb?
- Honduras ranks 120th and Netherlands ranks 123rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.